Substrate utilisation during exercise and shivering

It is generally assumed that exercise and shivering are analogous processes with regard to substrate utilisation and that, as a consequence, exercise can be used as a model for shivering. In the present study, substrate utilisation during exercise and shivering at the same oxygen consumption (V˙O₂) were compared. Following an overnight fast, eight male subjects undertook a 2-h immersion in cold water, designed to evoke three different intensities of shivering. At least 1 week later they undertook a 2-h period of bicycle ergometry during which the exercise intensity was varied to match the V˙O₂ recorded during shivering. During both activities hepatic glucose output (HGO), the rate of glucose utilisation (Rd), blood glucose, plasma insulin, free fatty acid (FFA) and beta-hydroxybutyrate (B-HBA) concentrations were measured. The V˙O₂ measured during the different levels of shivering averaged 0.49 l · min⁻¹ (level 1: low), 0.6 l · min⁻¹ (level 2: low-moderate), and 0.9 l · min⁻¹ (level 3: moderate), and corresponded closely to the levels measured during exercise. HGO and Rd were greater (P < 0.05) during exercise than during shivering at the same V˙O₂ (9.5% and 14.7%, respectively). The average (SD) HGO during level 3 exercise was 3.0 (0.91) mg · kg⁻¹ . min⁻¹ compared to 2.76 (1.0) mg · kg⁻¹ . min⁻¹ during shivering. The values for Rd were 3.06 (0.98) mg · kg⁻¹ · min⁻¹ during level 3 exercise and 2.68 (0.82) mg · kg⁻¹ · min⁻¹ during shivering. Blood glucose levels did not differ between conditions, averaging 5.4 (0.3) mmol . l⁻¹ over all levels of shivering and 5.2 (0.3) mmol · l⁻¹ during exercise. Plasma FFA and B-HBA were higher (P < 0.01) during shivering than during corresponding exercise (12.3% and 33.3%, respectively). FFA averaged 0.61 (0.2) mmol · l⁻¹ over all levels of shivering and 0.47 (0.16) mmol · l⁻¹ during exercise. The figures for B-HBA were 0.44 (0.13) mmol · l⁻¹ during all levels of shivering and 0.32 (0.1) mmol · l⁻¹ during exercise. Plasma insulin was higher (P < 0.05) during level 2 and 3 shivering compared to corresponding exercise; at these levels the average value for plasma insulin was 95.9 (21.9) pmol · l⁻¹ during shivering and 80.6 (16.1) pmol · l⁻¹ during exercise. On the basis of the present findings it is concluded that, with regard to substrate utilisation, shivering and exercise of up to 2 h duration should not be regarded as analogous processes. Accepted: 12 February 1997     

Eprinomectin in dairy goats: dose influence on plasma levels and excretion in milk

The plasma levels and milk excretion of eprinomectin were determined in goats following topical application at doses of 0.5 mg kg⁻¹ and 1.0 mg kg⁻¹. The area under the concentration–time curve (AUC) was 2 times lower for 0.5 mg kg⁻¹ (8.24 ± 3.50 ng day⁻¹ ml⁻¹) than for 1.0 mg kg⁻¹ (15.68 ± 8.84 ng day⁻¹ ml⁻¹), suggesting that the pharmacokinetics of eprinomectin in goats is dose independent. The bioavailability of eprinomectin in lactating compared with non-lactating goats is low. This is probably due to the physiological status of dairy animals, which present a marked decrease in body fat. Comparison of the eprinomectin concentrations in the milk and plasma demonstrated a parallel disposition of the drug with a milk-to-plasma ratio of 0.10–0.25. The amount of drug recovered in the milk was 0.3–0.5% of the total administered dose. In all cases, the maximum level of residue in milk remained below the maximum acceptable level of 30 ng ml⁻¹ permitted in lactating cattle. Received: 16 April 2000 / Accepted: 6 September 2000     

Measurement and prediction of peak shivering intensity in humans

Prediction equations of shivering metabolism are critical to the development of models of thermoregulation during cold exposure. Although the intensity of maximal shivering has not yet been predicted, a peak shivering metabolic rate (Shiv_peak) of five times the resting metabolic rate has been reported. A group of 15 subjects (including 4 women) [mean age 24.7 (SD 6) years, mean body mass 72.1 (SD 12) kg, mean height 1.76 (SD 0.1) m, mean body fat 22.3 (SD 7)% and mean maximal oxygen uptake (V˙O_2max) 53.2 (SD 9) ml O₂ · kg⁻¹ · min⁻¹] participated in the present study to measure and predict Shiv_peak. The subjects were initially immersed in water at 8°C for up to 70 min. Water temperature was then gradually increased at 0.8 °C · min⁻¹ to a value of 20 °C, which it was expected would increase shivering heat production based on the knowledge that peripheral cold receptors fire maximally at approximately this temperature. This, in combination with the relatively low core temperature at the time this water temperature was reached, was hypothesized would stimulate Shiv_peak. Prior to warming the water from 8 to 20 °C, the oxygen consumption was 15.1 (SD 5.5) ml · kg⁻¹ · min⁻¹ at core temperatures of approximately 35 °C. After the water temperature had risen to 20 °C, the observed Shiv_peak was 22.1 (SD 4.2) ml O₂ · kg⁻¹ · min⁻¹ at core and mean skin temperatures of 35.2 (SD 0.9) and 22.1 (SD 2.2) °C, respectively. The Shiv_peak corresponded to 4.9 (SD 0.8) times the resting metabolism and 41.7 (SD 5.1)% of V˙O_2max. The best fit equation predicting Shiv_peak was Shiv_peak (ml O₂ · kg⁻¹ · min⁻¹)=30.5 + 0.348 ×V˙O_2max (ml O₂ · kg⁻¹ · min⁻¹) − 0.909 × body mass index (kg · m⁻²) − 0.233 × age (years); (P=0.0001; r ²=0.872). Accepted: 7 September 2000     

Total energy expenditure of elite synchronized swimmers measured by the doubly labeled water method

To determine the daily energy requirement of elite synchronized swimmers during moderate-intensity training, the average daily energy expenditure measured by the doubly labeled water method, was calculated for nine female Japanese national team synchronized swimmers [four senior; mean (SD) 22.5 (1.0) years old, 52.2 (3.6) kg, and five junior; 17.6 (1.1) years old, 52.8 (2.3) kg]. Their total energy expenditure (TEE) was 11.5 (2.8) MJ · day⁻¹ [2738 (672) kcal · day⁻¹]. When compared with estimated energy requirements derived from “Recommended Dietary Allowances for the Japanese”, 12.1 (0.6) MJ · day⁻¹ [2897 (139) kcal · day⁻¹], there was no difference between mean actual and estimated energy requirements. However, there were considerable differences observed on an individual basis. Their energy intake, estimated from 7- day self-reported dietary records, was 8.9 (1.7) MJ · day⁻¹ [2128 (395) kcal · day⁻¹], which was significantly lower than their TEE (P < 0.05). Resting energy expenditure (REE), as determined by indirect calorimetry, was 5.2 (0.3) MJ · day⁻¹ [1247 (75) kcal · day⁻¹]. Their physical activity level (TEE/REE) was 2.18 (0.43). These results demonstrate that the TEE values of elite female synchronized swimmers are not dissimilar to those reported for athletes participating in other sports, especially competitive swimmers during moderate-intensity training. Accepted: 26 May 2000     

Influence of ultra-long-term fatigue on the oxygen cost of two types of locomotion

The aim of this study was to examine the effects of fatigue induced by a 65-km ultramarathon on the oxygen cost of running (C_r) and cycling (C_cycl). The day before and immediately after the race, a group of nine well-trained male subjects performed two sub-maximal 4-min exercise bouts: one cycling at a power corresponding to 1.5 W · kg⁻¹ body mass on an electromagnetically braked ergometer, and one running at 11 km · h⁻¹ on a flat asphalt roadway. Before oxygen cost determinations, the subjects performed 12 “ankle” jumps at a given frequency that was fixed by an electronic metronome (2.5 Hz). From the non-fatigued to the fatigued condition, there was a significant increase in minute ventilation for both running (P < 0.01) and cycling (P < 0.0001). Significant changes were also found in respiratory exchange ratio both for running (P=0.01) and cycling (P < 0.0001). However, running and cycling differed in that C_cycl increased significantly by [mean (SD)] 24.2 (11.5)% (P < 0.001), suggesting an alteration of muscle efficiency, while C_r did not change with fatigue [186.8 (14.1) mlO₂ · kg⁻¹ · km⁻¹ vs 186.8 (18.7) mlO₂ · kg⁻¹ · km⁻¹]. In addition, contact times during hopping increased significantly from 0.173 (0.019) ms to 0.194 (0.027) ms (P < 0.01). Analysis of the factors that determine C_r indicate that the subjects modified their movement pattern in order to decrease the mechanical cost of running in such long-term fatigue conditions. Accepted: 7 August 2000     

In vivo anthelmintic activity of chelidonine from Chelidonium majus L. against Dactylogyrus intermedius in Carassius auratus

Dactylogyrus intermedius is one of the most common and serious cause of parasitic diseases of freshwater fish in aquaculture, and can cause morbidity and high mortality in most species of freshwater fish worldwide. To attempt controlling this parasite and explore novel potential antiparasitic agents, the present study was designed to ascertain the anthelmintic activity of Chelidonium majus L. whole plant and to isolate and characterize the active constituents against D. intermedius. The ethanol extract from C. majus whole plant showed significant anthelmintic activity against D. intermedius [EC₅₀ (median effective concentration) value = 71.5 mg L⁻¹] and therefore subjected to further isolation and purification using various chromatographic techniques. A quaternary benzo[c]phenanthridine alkaloid exhibited significant activity against D. intermedius was obtained and identified as chelidonine. In vivo anthelmintic efficacy tests exhibited that chelidonine was 100% effective against D. intermedius at a concentration of 0.9 mg L⁻¹, with EC₅₀ value of 0.48 mg L⁻¹ after 48 h of exposure, which is more effective than the positive control, mebendazole (EC₅₀ value = 1.3 mg L⁻¹). In addition, the 48-h median lethal concentration (LC₅₀) for chelidonine against the host (Carassius auratus) was 4.54 mg L⁻¹. The resulting therapeutic index for chelidonine was 9.46. These results provided evidence that chelidonine might be potential sources of new antiparasitic drugs for the control of Dactylogyrus.     

In vitro and in vivo antimalarial activity of ferrochloroquine, a ferrocenyl analogue of chloroquine against chloroquine-resistant malaria parasites

Previous studies have shown that ferrochloroquine (FQ) exhibited an antimalarial activity against Plasmodium spp. The present work confirmed this activity, described the curative effect on P. vinckei and investigated the FQ toxicity in vitro and in vivo. The in vitro and in vivo growth inhibition of P. falciparum and P. berghei N, respectively, showed that FQ antimalarial activity was 1.5–10 times more potent than chloroquine. FQ completely inhibited the in vivo development of both chloroquine-susceptible and resistant P. vinckei strains and protected mice from lethal infection at a dose of 8.4 mg kg⁻¹ day⁻¹ given for 4 days subcutaneously or orally. This curative effect was 5–20 times more potent than chloroquine, according to the strains' resistance to chloroquine. At this curative dose, no clinical changes were observed in mice up to 14 days after the last administration. Nevertheless, the acute toxicity and lethality of ferrochloroquine seemed to be dependent on gastric surfeit. The FQ security index determined in vitro confirmed that it might be a promising compound. Received: 12 August 2000 / Accepted: 16 August 2000     

Attenuated β-adrenoceptor-mediated cardiac contractile responses following androgenic steroid administration to sedentary rats

Androgenic steroids administered in doses at pharmacological levels to sedentary animals have been shown to result in a reduced β-adrenoceptor-mediated increase in systolic cardiac performance when assessed in vivo. Whether the attenuated adrenergic response occurs as a consequence of alterations in either cardiac loads, heart rate, modifications in left ventricular (LV) geometry, or a decrease in myocardial contractile performance has not been determined. In this study the effect of chronic administration (over 3 months) of an androgenic steroid (nandrolone decanoate, 5 mg · kg⁻¹ biweekly) on the response of load-insensitive indices of myocardial contractile function [the slope of the LV systolic stress-strain relationship (LV-Eⁿ _max, where Eⁿ _max is systolic myocardial elastance)] to an adrenergic-inotropic stimulus was examined ex vivo in paced rat hearts. Systolic cardiac performance was assessed at 300 beats · min⁻¹ in isolated constant flow perfused heart preparations both before and during 10^−8.5 mol · l⁻¹ isoproterenol (ISO) infusion (approximate concentration of ISO eliciting 50% maximal inotropic response to ISO). Steroid administration resulted in left-shifted LV systolic and diastolic pressure-volume (P-V ) relationships. The leftshifted P-V relationships were attributed, in part, to increased slopes of these relationships. However, the steroid-mediated increment in the slope of the systolic P-V relationship (systolic chamber elastance, E_max) was not associated with a similar change in LV Eⁿ _max [control 19.2 (SEM 2.1) g · cm⁻², steroid 18.3 (SEM 2.4) g . cm⁻²] as determined in the absence of ISO. Isoproterenol infusion resulted in an increase in both E_max and Eⁿ _max in the control rats, without altering systolic performance in the steroid treated rats. Consequently, in the presence of ISO, the steroid treated rats exhibited a similar E_max, but a reduction in Eⁿ _max compared to the control rats [control 25.6 (SEM 1.9) g · cm⁻², steroid 18.5 (SEM 1.5) g · cm⁻²; P < 0.05]. In conclusion, these results would suggest that chronic high dose androgenic steroid administration produces a decrease in myocardial contractile reserve to β-adrenoceptor stimulation. Accepted: 3 September 1999     

The influence of prior cycling on biomechanical and cardiorespiratory response profiles during running in triathletes

The aim of the present study was to determine the effects of 40 km of cycling on the biomechanical and cardiorespiratory responses measured during the running segment of a classic triathlon, with particular emphasis on the time course of these responses. Seven male triathletes underwent four successive laboratory trials: (1) 40 km of cycling followed by a 10-km triathlon run (TR), (2) a 10-km control run (CR) at the same speed as TR, (3) an incremental treadmill test, and (4) an incremental cycle test. The following ventilatory data were collected every minute using an automated breath-by-breath system: pulmonary ventilation (V˙ _E, l · min⁻¹), oxygen uptake (V˙O₂, ml · min⁻¹ · kg⁻¹), carbon dioxide output (ml · min⁻¹), respiratory equivalents for oxygen (V˙ _E/V˙O₂) and carbon dioxide (V˙ _E/V˙CO₂), respiratory exchange ratio (R) respiratory frequency (f, breaths · min⁻¹), and tidal volume (ml). Heart rate (HR, beats · min⁻¹) was monitored using a telemetric system. Biomechanical variables included stride length (SL) and stride frequency (SF) recorded on a video tape. The results showed that the following variables were significantly higher (analysis of variance, P < 0.05) for TR than for CR: V˙O₂ [51.7 (3.4) vs 48.3 (3.9) ml · kg⁻¹ · min⁻¹, respectively], V˙ _E [100.4 (1.4) l · min⁻¹ vs 84.4 (7.0) l · min⁻¹], V˙ _E/V˙O₂ [24.2 (2.6) vs 21.5 (2.7)] V˙ _E/V˙CO₂ [25.2 (2.6) vs 22.4 (2.6)], f [55.8 (11.6) vs 49.0 (12.4) breaths · min⁻¹] and HR [175 (7) vs 168 (9) beats · min⁻¹]. Moreover, the time needed to reach steady-state was shorter for HR and V˙O₂ (1 min and 2 min, respectively) and longer for V˙ _E (7 min). In contrast, the biomechanical parameters, i.e. SL and SF, remained unchanged throughout TR versus CR. We conclude that the first minutes of the run segment after cycling in an experimental triathlon were specific in terms of V˙O₂ and cardiorespiratory variables, and nonspecific in terms of biomechanical variables. Accepted: 7 July 1997     

High-intensity exercise decreases muscle buffer capacity via a decrease in protein buffering in human skeletal muscle

We have previously reported an acute decrease in muscle buffer capacity (βm_{in vitro}) following high-intensity exercise. The aim of this study was to identify which muscle buffers are affected by acute exercise and the effects of exercise type and a training intervention on these changes. Whole muscle and non-protein βm_{in vitro} were measured in male endurance athletes (VO_2max = 59.8 ± 5.8 mL kg⁻¹ min⁻¹), and before and after training in male, team-sport athletes (VO_2max = 55.6 ± 5.5 mL kg⁻¹ min⁻¹). Biopsies were obtained at rest and immediately after either time-to-fatigue at 120% VO_2max (endurance athletes) or repeated sprints (team-sport athletes). High-intensity exercise was associated with a significant decrease in βm_{in vitro} in endurance-trained males (146 ± 9 to 138 ± 7 mmol H⁺·kg d.w.⁻¹·pH⁻¹), and in male team-sport athletes both before (139 ± 9 to 131 ± 7 mmol H⁺·kg d.w.⁻¹·pH⁻¹) and after training (152 ± 11 to 142 ± 9 mmol H⁺·kg d.w.⁻¹·pH⁻¹). There were no acute changes in non-protein buffering capacity. There was a significant increase in βm_{in vitro} following training, but this did not alter the post-exercise decrease in βm_{in vitro}. In conclusion, high-intensity exercise decreased βm_{in vitro} independent of exercise type or an interval-training intervention; this was largely explained by a decrease in protein buffering. These findings have important implications when examining training-induced changes in βm_{in vitro}. Resting and post-exercise muscle samples cannot be used interchangeably to determine βm_{in vitro}, and researchers must ensure that post-training measurements of βm_{in vitro} are not influenced by an acute decrease caused by the final training bout.     

The effect of diet on vitamin E intake and oxidative stress in response to acute exercise in female athletes

Vitamin E is the major lipid-soluble antioxidant found in foods, and its bioavailability is affected by the presence of dietary fats. Athletes often consume low-fat diets and may be more susceptible to the oxidative stress produced by exercise due to the low availability of vitamin E. In this study, the effects of a low-fat diet on vitamin E intake and oxidative stress markers were assessed in collegiate female rowers. All subjects habitually consumed either a low-fat (LF; <40 g fat · day⁻¹) or a high-fat (HF; >60 g fat · day⁻¹) diet. Subjects ran downhill for 45 min at 75% of their age-predicted maximal heart rate. Blood samples were collected immediately pre- and post-exercise, and at 6, 24, and 48 h post-exercise. Subjects in the LF group consumed significantly less vitamin E (2.9 mg vitamin E · day⁻¹) than advised by the Recommended Dietary Allowance (RDA; 8.0 mg vitamin E · day⁻¹) and than those in the HF group (9.8 mg vitamin E · day⁻¹; P < 0.05). Plasma concentrations of vitamin E, malondialdehyde, and conjugated dienes were not significantly different between LF and HF before or after exercise. Creatine kinase became significantly elevated above baseline at 6 h and 24 h post-exercise in both groups (P < 0.05). We can conclude from these data that although the subjects in the LF group were not consuming the recommended amount of vitamin E in their diets, their vitamin E intake appears to be sufficient to protect against the oxidative stress produced by this moderate-intensity exercise. Accepted: 28 April 2000     

Influence of body mass on maximal oxygen uptake: effect of sample size

Basal metabolic rate is scaled to body mass to the power of 0.73, and we evaluated whether a similar scaling applies when the O₂ transport capacity of the body is challenged during maximal exercise (i.e. at maximal O₂ uptake, V˙O _2max). The allometric relationship between V˙O _2max and body mass (y=a · x ^b, where y is V˙O _2max and x is body mass) was developed for 967 athletes representing 25 different sports, with up to 157 participants in each sport. With an increasing number of observations, the exponent approached 0.73, while for ventilation the exponent was only 0.55. By using the 0.73 exponent for V˙O _2max, the highest value [mean (SD)] for the males was obtained for the runners and cyclists [234 (16) ml · kg^−0.73 · min⁻¹], and for the females the highest value was found for the runners [189 (14) ml · kg^−0.73 · min⁻¹]. For the females, aerobic power was about 80% of the value achieved by the males. Scaling may help both in understanding variation in aerobic power and in defining the physiological limitations of work capacity. Accepted: 3 November 2000     

Dose-related elevations in venous pH with citrate ingestion do not alter 40-km cycling time-trial performance

The purpose of the current investigation was to determine whether sodium citrate enhances endurance cycling performance and, if so, what dosage(s) produces this effect. Eight trained [peak power output: 362 (48) W; power:weight: 5.1 (0.4) W · kg⁻¹, mean (SD)] male cyclists were requested to complete four, 40-km time-trials, each separated by 3–7 days, on their own bicycles, mounted on a Kingcycle ergometer. To mimic the stochastic nature of cycle road races, the time-trials included four 500-m, four 1-km and two 2-km sprints. The experimental conditions involved the ingestion of three dosages of sodium citrate dissolved in 400 ml water: 0.2 g · kg⁻¹, 0.4 g · kg⁻¹ and 0.6 g · kg⁻¹ body mass (b.m.) and a placebo (calcium carbonate, 0.1 g · kg⁻¹ b.m.). Subjects were asked to complete both the sprints and total distance in the fastest time possible. Venous blood samples were collected before, as well as at 10-km intervals during the trials for the analysis of plasma lactate and glucose concentrations and for the measurement of blood pH and PCO₂ levels. Immediately before, as well as during exercise, pH was significantly higher in the group ingesting the highest citrate dose (range 7.36–7.45) compared to the placebo (range 7.31–7.39) and the two lower citrate dosages. Despite this, no significant differences in power output (P=0.886) or time taken to complete the 40 km (P=0.754) were measured between the four trials. The average performance times (in min:s, with SD in parentheses) and average power output (in W) for the 40-km time-trials were: 58:46 (5:06) [265 (62) W], 60:24 (6:07) [251 (59) W], 61:47 (5:07) [243 (44) W] and 60:02 (5.05) [255 (55) W] for the 0.2, 0.4, 0.6 g · kg⁻¹ b.m. sodium citrate and placebo trials, respectively. There were also no significant differences measured between treatments in terms of time, power output, speed or heart rate during the 500-m, 1-km and 2-km sprints. The ingestion of increasing sodium citrate dosages before exercise produced dose-dependent changes in pH, base excess and HCO⁻ ₃ concentrations before and during the 40-km time-trial. However, these changes influenced neither the time-trial time nor the sprinting performance times. Accepted: 7 June 2000     

Nutritional status and physical fitness of elderly sportsmen

The nutritional status of elderly sportsmen has not been reported on, neither has the nutritional balance nor the precise relationship between nutritional status and physical fitness been detailed for this population. Thus, group of 18 sportsmen [age 63 (SD 4.5) years] was monitored by weighing their food during a 6-day period. Macro nutrient, mineral and vitamin content was derived from tables. Daily energy expenditure (DEE) and sport activity (DSA) were quantified over a 7-day period using a questionnaire. Physical fitness was assessed by maximal oxygen uptake (V˙O_2max) measurements. The DEE was 11 429 (SD 1890) kJ · day⁻¹. The DSA corresponded to 38% of DEE and V˙O_2max to 35.9 (SD 6.1) ml · min⁻¹ · kg⁻¹. When compared with French recommended dietary allowances (RDA) intakes were higher for energy (+24%), macro nutrients, and most minerals and vitamins. Despite high energy intakes, some subjects had mineral and vitamin deficits. Energy intakes were significantly related to intakes of magnesium, phosphorus, iron, vitamins B2, B6, C and to V˙O_2max, but not to age. Stepwise regressions indicated that vitamin C intake was the only determinant to have a relationship with V˙O_2max. Thus, most elderly sportsmen had higher nutritional status than RDA, although some had mineral and vitamin deficits. It is therefore suggested that elderly sportsmen should be encouraged to consume food with higher mineral and vitamin contents. Accepted: 17 June 1997     

The effect of endurance training on the ventilatory response to exercise in elite cyclists

The purpose of this study was to investigate the effects of endurance training on the ventilatory response to acute incremental exercise in elite cyclists. Fifteen male elite cyclists [mean (SD) age 24.3 (3.3) years, height 179 (6) cm, body mass 71.1 (7.6) kg, maximal oxygen consumption (V˙O_2max) 69 (7) ml · min⁻¹ · kg⁻¹] underwent two exercise tests on a cycle ergometer. The first test was assessed in December, 6 weeks before the beginning of the cycling season. The second test was performed in June, in the middle of the season. During this period the subjects were expected to be in a highly endurance-trained state. The ventilatory response was assessed during an incremental exercise test (20 W · min⁻¹). Oxygen consumption (V˙O₂), carbon dioxide production (V˙CO₂), minute ventilation (V˙ _E), and heart rate (HR) were assessed at the following points during the test: at workloads of 200 W, 250 W, 300 W, 350 W, 400 W and at the subject's maximal workload, at a respiratory exchange ratio (R) of 1, and at the ventilatory threshold (Th_vent) determined using the V-slope-method. Post-training, the mean (SD) V˙O_2max was increased from the pre-training level of 69 (7) ml · min⁻¹ · kg⁻¹ (range 61.4–78.6) to 78 (6) ml · min⁻¹ · kg⁻¹ (range 70.5–86.3). The mean post-training V˙O₂ was significantly higher than the pre training value (P < 0.01) at all work rates, at Th_vent and at R=1. V˙O₂ was also higher at all work rates except for 200 W and 250 W. V˙ _E was significantly higher at Th_vent and R=1. Training had no effect on HR at all workloads examined. An explanation for the higher V˙O₂ cost for the same work rate may be that in the endurance-trained state, the adaptation to an exercise stimulus with higher intensity is faster than for the less-trained state. Another explanation may be that at the same work rate, in the less-endurance-trained state power is generated using a significantly higher anaerobic input. The results of this study suggest the following practical recommendations for training management in elite cyclists: (1) the V˙O₂ for a subject at the same work rate may be an indicator of the endurance-trained state (i.e., the higher the V˙O₂, the higher the endurance-trained capacity), and (2) the need for multiple exercise tests for determining the HR at Th_vent during a cycling season is doubtful since at Th_vent this parameter does not differ much following endurance training. Accepted: 19 October 1999     

The effects of 3000-m swimming on subsequent 3-h cycling performance: implications for ultraendurance triathletes

The purpose of this study was to examine the physiological effects of 3000-m swimming on subsequent 3-h cycling time trial performance in ultraendurance triathletes. Eight highly trained ultraendurance triathletes [mean (SEM) age 34 (2) years, body fat 12.5 (0.8)%, maximum oxygen consumption 63.2 (2.1) ml · kg⁻¹ · min⁻¹] completed two randomly assigned trials 1 week apart. The swim/bike trial (SB) involved 3000 m of swimming [min:s 52:28 (1:48)] immediately followed by a 3-h cycling performance at a self-selected time-trial pace. The control trial (CON) consisted of an identical 3-h cycling time trial but without prior swimming. Subjects consumed an 8% carbohydrate (CHO)/electrolyte beverage during both trials at the rate of 60 g CHO · h⁻¹ and 1 l · h⁻¹. No significant differences were evident between CON and SB on the dependent measures (CON vs SB): power output [W˙, 222 (14) W vs 212 (13) W], heart rate [f _c, 147 (5) beats · min⁻¹ vs 143 (4) beats · min⁻¹; %f _cmax 80.0 (1.6)% vs 78.4 (1.5)%], oxygen uptake [3.10 (0.12) l · min⁻¹ vs 2.97 (0.15) l · min⁻¹], minute ventilation [82.5 (4.4) l · min⁻¹ vs 77.3 (3.7) l · min⁻¹], rating of perceived exertion [14.6 (0.4) vs 14.0 (0.1)], blood lactate [6.1 (0.5) mmol · l⁻¹ vs 4.8 (0.5) mmol · l⁻¹], and blood glucose [5.0 (0.2) mmol · l⁻¹ vs 5.3 (0.1) mmol · l⁻¹; all non-significant at the P > 0.05 level]. However, the CON respiratory exchange ratio was significantly greater than for SB [0.91 (0.01) vs 0.89 (0.01); P < 0.05], suggesting that the SB trial required a greater reliance on lipid as a fuel substrate. Hence, the main finding in the present study was that 3000 m of swimming had no significant performance effect (in terms of W˙) on subsequent 3-h cycling performance in ultraendurance triathletes. Accepted: 2 March 2000     

The effects of drafting on stroking variations during swimming in elite male triathletes

The aim of this study was to determine the effects of drafting behind another swimmer on the metabolic response and stroke characteristics. Six highly trained male triathletes performed two maximal 400-m swims, one in a drafting (D) and one in a non-drafting condition (ND). Their metabolic response was assessed by measuring the oxygen uptake (V˙O₂) and the blood lactate concentration at the end of each 400 m. Swimming velocity, stroke frequency, stroke length, and stroke index (velocity multiplied by stroke length) were recorded every 50 m. In the D and ND conditions, there was no difference in V˙O₂ [66.7 (1.7) ml · kg⁻¹ · min⁻¹ vs 65.6 (1.2) ml · kg⁻¹ · min⁻¹, respectively], however, the lactate concentrations were lower in D than in ND [9.6 (0.9) mM vs 10.8 (0.9) mM, respectively, P < 0.01]. In D, the performance [1.39 (0.02) m · s⁻¹ vs 1.34 (0.02) m · s⁻¹, respectively, P < 0.01] and the stroking parameters (i.e., stroke length and stroke index) increased significantly, while the stroke frequency remain unchanged. In D, a stable pace was maintained, while in ND, velocity decreased significantly throughout the 400 m. In D, the performance gains were related to the 400-m D velocity (r=0.78, P < 0.05), and to the body fat mass (BFM, r=0.99, P < 0.01). The stroke index in D was also related to BFM (r=0.78, P < 0.05). Faster and leaner swimmers achieved greater performance gains and stroke index when drafting. Thus, drafting during swimming increases the performance and contributes to the maintenance of stable stroking parameters such as stroke frequency and stroke length during a 400-m swim. Accepted: 10 April 2000     

Simulated moderate altitude elevates serum erythropoietin but does not increase reticulocyte production in well-trained runners

The purpose of this study was to investigate whether the modest increases in serum erythropoietin (sEpo) experienced after brief sojourns at simulated altitude are sufficient to stimulate reticulocyte production. Six well-trained middle-distance runners (HIGH, mean maximum oxygen uptake, V˙O_2max = 70.2 ml · kg⁻¹ · min⁻¹) spent 8–11 h per night for 5 nights in a nitrogen house that simulated an altitude of 2650 m. Five squad members (CONTROL, mean V˙O_2max = 68.9 ml · kg⁻¹ · min⁻¹) undertook the same training, which was conducted under near-sea-level conditions (600 m altitude), and slept in dormitory-style accommodation also at 600 m altitude. For both groups, this 5-night protocol was undertaken on three occasions, with a 3-night interim between successive exposures. Venous blood samples were measured for sEpo after 1 and 5 nights of hypoxia on each occasion. The percentage of reticulocytes was measured, along with a range of reticulocyte parameters that are sensitive to changes in erythropoiesis. Mean serum erythropoietin levels increased significantly (P < 0.01) above baseline values [mean (SD) 7.9 (2.4) mU · ml⁻¹] in the HIGH group after the 1st night [11.8 (1.9) mU · ml⁻¹, 57%], and were also higher on the 5th night [10.7 (2.2) mU · ml⁻¹, 42%] compared with the CONTROL group, whose erythropoietin levels did not change. After athletes spent 3 nights at near sea level, the change in sEpo during subsequent hypoxic exposures was markedly attenuated (13% and −4% change during the second exposure; 26% and 14% change during the third exposure; 1st and 5th nights of each block, respectively). The increase in sEpo was insufficient to stimulate reticulocyte production at any time point. We conclude that when daily training loads are controlled, the modest increases in sEpo known to occur following brief exposure to a simulated altitude of 2650 m are insufficient to stimulate reticulocyte production. Accepted: 7 October 1999     

Blood metabolite and catecholamine responses to prolonged exercise following either acute plasma volume expansion or short-term training

 To determine the effect of acute plasma volume (PV) expansion on substrate utilization, blood metabolites and catecholamines to prolonged, moderate intensity cycle exercise, eight untrained men mean maximal oxygen uptake,O_2max 4.10 (SEM 0.32) l · min⁻¹ were infused (10 ml·kg⁻¹) with a 6% dextran (DEX) solution. These responses were also compared to those elicited using a short-term training (TR) protocol involving cycling for 90 to 120 min · day⁻¹ at 60% O_2max for 3 consecutive days. In general DEX, which resulted in a calculated expansion of PV by 23.9%, was without effect in modifying exercise oxygen uptake or the reduction in the respiratory exchange ratio (R) observed during prolonged exercise. In addition, the concentrations of blood glucose, glycerol, alanine and serum free fatty acids, although altered (P < 0.05) by exercise, were not altered by DEX. Blood lactate concentration was only higher (P < 0.05) at 30 min of exercise during DEX compared to the control. With the exception of blood lactate concentration, which was reduced (P < 0.05), TR did not change R or the concentrations of other blood metabolites. The concentrations of nonadrenaline and adrenaline, were depressed (P < 0.05) by DEX and TR at 60 and 90 min of exercise. These results would suggest that mechanisms as yet undefined can compensate for the estimated 10% reduction in arterial oxygen content mediated by acute PV expansion and enable prolonged exercise to be performed without adjustments in substrate selection and substrate mobilization. Accepted: 23 August 1996     

Beneficial Effects of TLR-2/6 Ligation in Pulmonary Bacterial Infection and Immunization with <Emphasis Type="Italic">Pseudomonas aeruginosa</Emphasis>

Pseudomonas aeruginosa (P. aeruginosa) is the major pathogen in nosocomial and life-threatening infections of immunocompromised or critically ill patients. The macrophage-activating lipopeptide-2 (MALP-2) activates the immune system via Toll-like receptors (TLR) 2 and 6 and leads to an accumulation of immune cells in lungs of young adult (8–10 week old) rats after intratracheal application. This is characterized by a high increase of granulocyte numbers in the BAL 24 h after MALP-2 treatment. It was hypothesized that MALP-2 may have a positive effect on the clinical course of an experimental infection. Therefore, rats were treated with MALP-2 at different time points following an infection with P. aeruginosa. The effect of MALP-2 in combination with immunization with inactivated P. aeruginosa was also investigated. Rats (n = 10) were infected intratracheally (i.t.) with 1 × 10⁸ CFU P. aeruginosa on day 0. They were treated on day −3, −1, 0 and +1 with 2.5 μg MALP-2 or the vehicle i.t. In additional experiments, rats were immunized on day −21 and −14 with 1 × 10⁸ CFU of inactivated P. aeruginosa bacteria and 2.5 μg MALP-2 or vehicle with 1 × 10⁸ CFU of inactivated bacteria and isopropanol. The clinical score, rectal temperature and weight of the rats were checked in both treatment and immunization experiments twice a day. On day 2 they were sacrificed, CFU were determined in the left lung, the right lung being used for histology. In the group treated with MALP-2 1 day prior to infection significant effects were seen: The rectal temperature was about 2°C higher in comparison to the controls at 6 h and also 1 day after infection. Both the symptoms of the infection and the weight loss were significantly reduced. In addition, the CFU and the inflammation in the lung tissue were significantly lower. These effects were not observed after treatment on day −3, 0 or +1. The MALP-2 enhanced immunization only resulted in a tendency to clinical improvement. In conclusion, local immunostimulation at the appropriate time can enhance the host defense against bacteria in the lung.